Mandate

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.

The acquisition will enable SunMind to further enrich its expertise in renewable solar energy and other sources of renewable energy.

The current owners of Helios will receive an upfront payment of approximately EUR 73 million as well as a substantial earnout component tied to Helios's portfolio of unsold projects stretching over five years from closing.

The acquisition is subject to customary regulatory approvals.

Vinge's team primarily consisted of Peter Sundgren, Martin E Svanberg, Hanna Jansson and Fredrik Löwenclou (M&A), Amelia Rihs (Employment), Johan Cederblad and Lina Österberg (Environmental law), Kristoffer Larsson and Jasdeep Singh (Real Estate), Jolene Reimersson och Mario Saad (Commercial Agreements), Mia Falk (Compliance), David Olander and Lovisa Lewin (Regulatory),  Cecilia Loctander and  Caroline Löv (Transaction Support Coordinators).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025